Chronic endothelin A receptor blockade in lambs with increased pulmonary blood flow and pressure

Sohrab Fratz, Barbara Meyrick, Boaz Ovadia, Michael J. Johengen, Olaf Reinhartz, Anthony Azakie, Greg Ross, Robert Fitzgerald, Peter Oishi, John Hess, Stephen M. Black, Jeffrey R. Fineman

Research output: Contribution to journalArticle

11 Scopus citations

Abstract

Endothelin receptor blockade is an emerging therapy for pulmonary hypertension. However, hemodynamic and structural effects and potential changes in endogenous nitric oxide (NO)-cGMP and endothelin-1 signaling of chronic endothelin A receptor blockade in pulmonary hypertension secondary to congenital heart disease are unknown. Therefore, the objectives of this study were to determine hemodynamic and structural effects and potential changes in endogenous NO-cGMP and endothelin-1 signaling of chronic endothelin A receptor blockade in a lamb model of increased pulmonary blood flow following in utero placement of an aortopulmonary shunt. Immediately after spontaneous birth, shunt lambs were treated lifelong with either an endothelin A receptor antagonist (PD-156707) or placebo. At 4 wk of age, PD-156707-treated shunt lambs (n = 6) had lower pulmonary vascular resistance and right atrial pressure than placebo-treated shunt lambs (n = 8, P < 0.05). Smooth muscle thickness or arterial number per unit area was not different between the two groups. However, the number of alveolar profiles per unit area was increased in the PD-156707-treated shunt lambs (190.7 ± 5.6 vs. 132.9 ± 10.0, P < 0.05). Plasma endothelin-1 and cGMP levels and lung NOS activity, cGMP, eNOS, preproendothelin-1, endothelin-converting enzyme-1, endothelin A, and endothelin B receptor protein levels were similar in both groups. We conclude that chronic endothelin A receptor blockade attenuates the progression of pulmonary hypertension and augments alveolar growth in lambs with increased pulmonary blood flow.

Original languageEnglish (US)
Pages (from-to)L592-L597
JournalAmerican Journal of Physiology - Lung Cellular and Molecular Physiology
Volume287
Issue number3 31-3
DOIs
StatePublished - Sep 1 2004

Keywords

  • Congenital heart defect
  • Pulmonary heart disease

ASJC Scopus subject areas

  • Physiology
  • Pulmonary and Respiratory Medicine
  • Physiology (medical)
  • Cell Biology

Fingerprint Dive into the research topics of 'Chronic endothelin A receptor blockade in lambs with increased pulmonary blood flow and pressure'. Together they form a unique fingerprint.

  • Cite this

    Fratz, S., Meyrick, B., Ovadia, B., Johengen, M. J., Reinhartz, O., Azakie, A., Ross, G., Fitzgerald, R., Oishi, P., Hess, J., Black, S. M., & Fineman, J. R. (2004). Chronic endothelin A receptor blockade in lambs with increased pulmonary blood flow and pressure. American Journal of Physiology - Lung Cellular and Molecular Physiology, 287(3 31-3), L592-L597. https://doi.org/10.1152/ajplung.00093.2004